Sign in

CIK 0001799191

  • Accelerated filer
  • Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN STLNW DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843562323
Phone
+1 562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Common stock Nasdaq
  • DFPH Common stock OTC
Open-market buys, last 90 days
$176,273
in 1 filing
Open-market sales, last 90 days
$13,322,043
in 2 filings, $1.9M under 10b5-1 plans

Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Chernett Jorey −$11.2M 10% owner sold 27% of stake
  2. Hively Brad −$1.9M Director sold 42% of stake
Date Insider Transaction Shares Price Value Owned after
2025-11-20 Ling Gabriel Director Grant or award +46,296 296,502
2025-11-20 Ling Gabriel Director Grant or award +37,037 333,539
2025-11-18 Ling Gabriel Director Other acquisition +141,149 250,206
2024-11-22 Ling Gabriel Director Grant or award +40,000 109,057
2023-12-26 Ling Gabriel Director Grant or award +40,000 69,057
2022-11-17 Ling Gabriel Director Grant or award +29,057 29,057

Page 1 of 1 · 6 trades